EuBiologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 15 shareholders own 23.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.8%	BioNote, Inc.	6,850,953	₩87.3b	0%	no data
3.2%	The Vanguard Group, Inc.	1,170,317	₩14.9b	0.24%	no data
0.68%	Dimensional Fund Advisors LP	248,319	₩3.2b	0%	no data
0.51%	Samsung Asset Management Company, Ltd.	185,541	₩2.4b	0%	0.01%
0.15%	Charles Schwab Investment Management, Inc.	55,666	₩709.2m	0%	no data
0.12%	Norges Bank Investment Management	43,663	₩556.3m	0%	no data
0.08%	KB Asset Management Co., Ltd.	29,348	₩373.9m	0%	no data
0.072%	State Street Global Advisors, Inc.	26,402	₩336.4m	0%	no data
0.06%	Young-sik Jo	22,074	₩281.2m	0%	no data
0.049%	Innocence Co. Ltd	18,074	₩230.3m	0%	no data
0.047%	NH-Amundi Asset Management	17,088	₩217.7m	0%	0.01%
0.032%	SHINYOUNG Asset Management Co., Ltd.	11,735	₩149.5m	0%	0.01%
0.0042%	Midas Asset Management	1,527	₩19.5m	0%	no data
0.0013%	Invesco Capital Management LLC	486	₩6.2m	0%	no data
0.00088%	Mirae Asset Global Investments Co., Ltd.	323	₩4.1m	0%	no data